Overview
This clinical trial tests how well cognitive behavioral cancer stress management (CBCSM) group sessions work to decrease psychological distress in cancer patients. CBCSM teaches patients how to recognize and reduce the impacts of cancer associated stress on the biological, psychological, and social life domains.
Description
PRIMARY OBJECTIVE:
I. To reduce psychological stress.
SECONDARY OBJECTIVES:
I. To increase post-traumatic growth (PTG). II. To increase patient self-efficacy in utilizing therapy skills. III. To estimate patient acceptability and feasibility of conducting CBCSM within the clinical setting.
OUTLINE: Patients are assigned to 1 of 2 groups.
GROUP I: Patients participate in five CBCSM group sessions on study. Patients complete questionnaires throughout the trial.
GROUP II: Patients complete questionnaires throughout the trial.
Eligibility
Inclusion Criteria:
- Eligible for the cognitive behavioral cancer stress management (CBCSM) clinical service
- Cancer diagnosis with predicted survival > 1 year
- Cancer treatment within past 1 year or treatment planning in progress
- Age >= 18-years
- Moderate distress screen, indicated by Impact of Event Scale-Revised (IES-R) score >= 14 or clinical judgment
- Written informed research consent
Exclusion Criteria:
- Inability to actively participate in and learn from group therapy (e.g., psychotic symptoms, neurological condition, personality pathology) as determined by clinical judgment in clinical consultation (Individual therapy or alternative group therapy will be offered)